Results 101 to 110 of about 1,589,244 (139)

Inflammation and vasopressin hypersecretion in aging. [PDF]

Front Endocrinol (Lausanne)
Mutig K, Lebedeva S, Singh PB.
europepmc   +1 more source

Structural insights into antagonist recognition by the vasopressin V2 receptor. [PDF]

Nat Commun
Zhang T, Liu H, You C, Zhang Y, Xu Y, Pan B, Wu C, Jin S, Yin YL, Wu K, Chen Y, Sun H, Si Y, Tan Y, Yin W, Xu HE, Guo D, Jiang Y.   +17 more
europepmc   +1 more source

Diuretics in Cardiovascular Disease: For How Long and at What Dose? [PDF]

J Cardiovasc Dev Dis
Paraskevaidis I, Tsougos E, Kourek C.
europepmc   +1 more source

Specialty grand challenge: existing issues and emerging frontiers in renal endocrinology. [PDF]

Front Endocrinol (Lausanne)
Haque ATME, Razzaque MS.
europepmc   +1 more source

Successful treatment of chronic alcohol-induced refractory hyponatremia with tolvaptan: a case report with in-depth analysis of traditional treatment failure mechanisms. [PDF]

Front Pharmacol
Yan K, Zhou J, Zeng H, Liu D, Tao W, Fang Z, Yang X.   +6 more
europepmc   +1 more source

Emerging Medical Therapies for Primary Aldosteronism. [PDF]

Hypertension
Vibhatavata P, Turcu AF.
europepmc   +1 more source

Fewer Injections and Lower Drug Costs With Long-Acting GnRH Depot Formulations: A Nationwide Analysis of 2.3 Million Patient-Years in Japan. [PDF]

Cancer Rep (Hoboken)
Kawahara T, Hashizume A, Yamazaki M, Takamoto D, Takeshima T, Uemura H, Makiyama K, Teranishi JI.   +7 more
europepmc   +1 more source

The expanding role of peptides in cardiovascular care. [PDF]

Diab Vasc Dis Res
Pabón Romero AF, Martínez C.
europepmc   +1 more source

Effectiveness and hepatic safety of short-term low-dose tolvaptan for severe hyponatremia: A retrospective comparative study. [PDF]

Medicine (Baltimore)
Uyar S, Kaplan Çayir M, Koca N.
europepmc   +1 more source

Hydroelectrolytic syndromes in neuroanesthesia and neurocritical care. [PDF]

World J Crit Care Med
Mejia Herrera F, Marino L, Bilotta F.
europepmc   +1 more source